Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration [Yahoo! Finance]
Privia Health Group, Inc. (PRVA)
Company Research
Source: Yahoo! Finance
Amalgam Rx, Inc., Privia Health, and Exact Sciences Corp. highlight how coordinated, EHR-enabled patient outreach supported measurable screening impact at scale. Amalgam Rx, Inc., Privia Health, and Exact Sciences Corp. highlight how coordinated, EHR-enabled patient outreach supported measurable screening impact at scale. WILMINGTON, Del., March 03, 2026 BUSINESS WIRE Amalgam Rx, Inc ., a leader in data-driven, AI-powered healthcare engagement and clinical decision support, today announced results from a Privia Health (NASDAQ: PRVA)-led colorectal cancer (CRC) screening program, supported by Amalgam Rx, Inc. and Exact Sciences Corp. (NASDAQ: EXAS). Documented in a published Privia Health case study, the program demonstrates how EHR-integrated workflows and proactive patient outreach supported an increase of CRC screening rates to 84% in 2024, exceeding national benchmarks and surpassing the National Colorectal Cancer Roundtable's 80% screening goal. With March recognized as Col
Show less
Read more
Impact Snapshot
Event Time:
PRVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRVA alerts
High impacting Privia Health Group, Inc. news events
Weekly update
A roundup of the hottest topics
PRVA
News
- Privia Health Group (PRVA) had its price target lowered by Citigroup Inc. from $34.00 to $32.00. They now have a "buy" rating on the stock.MarketBeat
- Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry CollaborationBusiness Wire
- Privia Health price target raised to $33 from $31 at Truist [Yahoo! Finance]Yahoo! Finance
- Privia Health Group (PRVA) had its price target raised by Truist Financial Corporation from $31.00 to $33.00. They now have a "buy" rating on the stock.MarketBeat
- Privia Health Group (PRVA) Is Up 8.0% After Raising 2026 Revenue Guidance and Beating Q4 Targets [Yahoo! Finance]Yahoo! Finance
PRVA
Earnings
- 2/26/26 - Beat
PRVA
Sec Filings
- 3/2/26 - Form 4
- 3/2/26 - Form 4
- 2/27/26 - Form 144
- PRVA's page on the SEC website